Tech traders ought to be watching Covalon Applied sciences, this analyst says

Analysis Capital analyst Andre Uddin maintained his “Purchase” score and C$2.90 value goal on Covalon Applied sciences (Covalon Applied sciences Inventory Quote, Chart, Information, Analysts, Financials TSXV:COV) in a February 25 healthcare replace, following what he characterised as a smooth fiscal first quarter.

Covalon reported Q1 fiscal 2026 income of $6.9-million for the interval ended Dec. 31, 2025, beneath Uddin’s $8.9-million estimate and down 16% year-over-year from $8.2-million. He attributed the shortfall primarily to lingering disruption from the possession transition of a U.S. Superior Wound Care strategic accomplice and pricing changes in that channel.

Uddin stated the weak point seems momentary.

Administration indicated that income recorded throughout the first half of fiscal Q2 (Jan. 1 to Feb. 15) has already exceeded the complete Q1 whole of $6.9-million, suggesting bettering momentum into fiscal 2026. Uddin expects Q2 income of $9.3-million and a return to progress.

Gross margin in Q1 was 58%, above his 56% estimate however beneath 61% final yr, reflecting product combine and pricing changes. Adjusted EBITDA was $0.4-million, in contrast along with his $1.6-million forecast and $1.5-million within the prior yr.

Internet revenue was $0.1-million, or $0.004 per absolutely diluted share, versus Uddin’s estimate of $1.3-million, or $0.04 per share.

In the course of the quarter, Covalon added 12 new hospital clients, and Uddin continues to see the Vascular Entry portfolio as the first progress driver over the subsequent 5 years. The corporate additionally not too long ago obtained new manufacturing tools and expects automation to enhance working efficiencies.

As of Dec. 31, Covalon had $17.9-million in money and no debt.

Uddin stated he continues to view the corporate as a growth-at-a-reasonable-price alternative, noting the inventory has declined over the previous 5 quarters on weaker-than-expected gross sales however might see enchancment as income rebounds in Q2.

-30-

Cantech Letter founder and editor Nick Waddell has lived in 5 Canadian provinces and is pleased with his nation’s typically neglected contributions to the world of science and expertise. Waddell takes an everyday shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications comparable to Canadian Enterprise and Enterprise Insider.